个性化文献订阅>期刊> Expert Opinion on Therapeutic Targets
 

Targeting the JAK2/STAT3 axis in Alzheimer's disease

  作者 Chiba, T; Yamada, M; Aiso, S  
  选自 期刊  Expert Opinion on Therapeutic Targets;  卷期  2009年13-10;  页码  1155-1167  
  关联知识点  
 

[摘要]Background: Amyloid P (A beta) has long been implicated in the pathogenesis of Alzheimer's disease (AD). Little is known, however, about the intracellular events in neurons which lead to memory loss related to AD. Focusing on the fact that an AD-specific neuroprotective peptide named humanin (HN) inhibits AD-related neurotoxicity by activating the JAK2/STAT3 signaling axis, we recently found that age- and disease-dependent deterioration in the JAK2/STAT3 axis plays a critical role in the pathogenesis of AD. Objective/methods: Here we summarize the neuroprotective effect of HN and its derivative, named colivelin (CLN), and also review the roles of the JAK2/STAT3 axis in memory impairment related to AD. Results/condusions: The JAK2/STAT3 axis is a major transducer of HN-mediated neuroprotective activity. A beta-dependent inactivation of the JAK2/STAT3 axis in hippocampal neurons causes cholinergic dysfunction via pre- and post-synaptic mechanisms, which leads to memory impairment related to AD. This provides not only a novel pathological hallmark of AD but also a novel target in AD therapy.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内